#VisualAbstract: Infrequent Zoledronate over 10 years Prevents Frcatures in Early Postmenopausal Women
Click here to read this study in NEJM. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Tag: osteoporosis
Denosumab may increase risk of major adverse cardiovascular events but reduce fracture risk in patients receiving dialysis
1. In this target trial emulation study, denosumab was associated with an increased risk of major adverse cardiovascular events compared ...
Denosumab increases risk of severe hypocalcemia in women with osteoporosis and chronic kidney disease
1. In this target trial emulation study, denosumab was found to increase the risk of hypocalcemia requiring emergency treatment as ...
Long-term calcium and vitamin D supplementation does not impact all-cause mortality
1. In this randomized controlled trial, long-term calcium and vitamin D (CaD) supplementation was associated with lower cancer mortality and ...
Corticosteroid injections not found to be associated with fracture risk in elderly cohort
1. In a cohort of older adults, the use of corticosteroid injections (CSIs) was not associated with increased fracture risk, ...
Osteoporosis prevalence in patients undergoing peritoneal dialysis is not correlated with vitamin D levels
1. In patients undergoing peritoneal dialysis, osteoporosis is highly prevalent but does not correlate to 25-vitamin D levels. Evidence Rating ...
Osteoporosis and fracture risk increased following benign hysterectomy among female patients in Korea
1. This large retrospective cohort study found that female patients who underwent a hysterectomy with or without an adnexal surgical ...
2 Minute Medicine Rewind September 18, 2023
Non-erosive gastro-oesophageal reflux disease and incidence of oesophageal adenocarcinoma in three Nordic countries: population based cohort study 1. Patients with ...
Denosumab for osteoporosis is associated with reduced diabetes risk compared to bisphosphonates
1. In a cohort of adults with osteoporosis, the use of denosumab was linked to a reduced risk of developing ...
Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated with reduced clinical fractures in postmenopausal patients with osteoporosis. 2. ...